iHeart

VitalSines is a Health Care startup founded in 2012 and headquartered in Canada. The company's flagship product, iheart Internal Age, is a groundbreaking health monitoring device and mobile app that assesses the user's Internal Age in just 30 seconds. By measuring Aortic Stiffness, a scientifically proven heart health metric, it provides valuable insights into the risk of heart disease, cognitive decline, dementia, and overall mortality. Previously, obtaining this critical health parameter required a $25,000 medical device, but iheart offers the same results for less than $200, validated against the medical 'gold standard'. The latest investment, a Non-Equity Assistance investment, was secured on 01 January 2018 from Spring Activator. The company's mission is to revolutionize health monitoring by offering a new perspective of the human body. VitalSines aims to empower consumers with actionable information, enabling them to make informed decisions about their health and ultimately lead longer, healthier lives. The team is driven by a passion for developing products that educate users about the impact of their daily actions on their internal health and lifespan. With its innovative approach and promising product offering, VitalSines presents an attractive proposition for venture capital investment in the rapidly evolving health tech sector.